Armistice Capital’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,325
Closed -$574K 381
2025
Q4
$574K Buy
9,325
+5,075
+119% +$290K 0.01% 206
2025
Q3
$223K Sell
4,250
-56,750
-93% -$2.86M ﹤0.01% 298
2025
Q2
$2.75M Buy
+61,000
New +$2.52M 0.05% 123
2025
Q1
Sell
-53,000
Closed -$2.45M 265
2024
Q4
$2.45M Sell
53,000
-117,477
-69% -$6.02M 0.03% 146
2024
Q3
$8.96M Buy
+170,477
New +$8.45M 0.14% 98
2021
Q1
Sell
-172,000
Closed -$11.4M 123
2020
Q4
$11.4M Buy
172,000
+122,000
+244% +$6.78M 0.39% 66
2020
Q3
$2.26M Buy
+50,000
New +$2.42M 0.08% 89

Other funds holding LIVN

Armistice Capital's LIVN Position: Q1 2026 in Review

Armistice Capital sold out of LivaNova (LIVN) in Q1 2026, closing a stake of 9,325 shares — an estimated $574K sold.

Armistice Capital first reported a position in LIVN in Q3 2020 and held it in 7 quarters. The position peaked at $11.4M in Q4 2020. 290 funds tracked by Wall St. Rank hold LIVN as of Q1 2026.

  • Armistice Capital reported no remaining LivaNova position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 9,325 LivaNova shares in Q1 2026, an estimated $574K.
  • Armistice Capital first reported a position in LivaNova in Q3 2020 and held it in 7 quarters.
  • Armistice Capital's LivaNova position peaked at $11.4M in Q4 2020.
  • 290 funds tracked by Wall St. Rank held LivaNova as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.